LMP is responsible for lysosomal dysfunction in IDD. The lipid composition changes in the lysosomal membrane, mediated by PLA2G15, are the cause of LMP. The C/EBPα significantly promotes PLA2G15 expression under PA overload stress. Inhibition of PLA2G15 alleviates PA‐induced LMP by inhibiting the hydrolysis of lysosomal membrane phospholipids. ABSTRACT
Liqun Duan +7 more
wiley +1 more source
Bovine Milk Polar Lipids: Lipidomics Advances and Functional Perspectives. [PDF]
Fappani G +3 more
europepmc +1 more source
ABSTRACT Knowledge of the potential of biomarkers for monitoring clinical improvement, assessing trajectory or disease progression in advanced chronic liver disease is still insufficient. This study investigated biomarkers of fibrosis and macrophage activation over time in newly diagnosed patients with cirrhosis and their potential association with ...
Emilie Toft Skovgaard +8 more
wiley +1 more source
The integration of plasma non-target metabolomics and lipidomics analysis for the discovery of global developmental delay/intellectual disability biomarkers. [PDF]
Chen B +6 more
europepmc +1 more source
Effect of Vitrification on Lipidomics in Porcine Cumulus-Oocyte Complexes After In Vitro Maturation. [PDF]
Huang X +8 more
europepmc +1 more source
Integrating mass spectrometry-based multi-omic signatures of extracellular vesicles: from discovery to clinical translation. [PDF]
Wijerathna-Yapa A +2 more
europepmc +1 more source
Plasma proteomics stratification identifies phospholamban R14del carriers at risk for disease progression. [PDF]
Deiman FE +13 more
europepmc +1 more source
Plasma lipidomics, choline metabolites, and metabolic-associated steatotic liver disease (MASLD): A Coronary Artery Risk Development in Young Adults (CARDIA) study. [PDF]
Sprinkles JK +11 more
europepmc +1 more source

